GlassScriptPhysician profile
Donielle A Daigle
NPI 1376566869
$1,560.74
in general payments reported to CMS, 2019-2025
21 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $138 · 2021: $424 · 2022: $279 · 2023: $199 · 2024: $214 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.91 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $359.55 | 2019-2023 | Lo Loestrin Fe |
| Pfizer INC. | $179.43 | 2022-2025 | |
| Hologic Sales and Service, LLC | $132.27 | 2020-2024 | Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $106.51 | 2023-2025 | |
| Sage Therapeutics, LLC | $73.78 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $73.57 | 2022 | |
| Sumitomo Pharma America, INC. | $59.93 | 2023-2024 | Myfembree |
| Agile Therapeutics, INC. | $56.76 | 2021-2022 | |
| Astellas Pharma US INC | $54.45 | 2024-2025 | Veozah |
| Daiichi Sankyo INC. | $51.03 | 2021-2022 | |
| Organon LLC | $50.39 | 2021-2024 | Nexplanon |
| Evofem Biosciences, INC. | $49.92 | 2020-2021 | |
| Aspira Women'S Health INC | $48.04 | 2021 | |
| Therapeuticsmd, INC. | $44.55 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $44.36 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $43.85 | 2021-2023 | |
| Millicent US INC | $36.06 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $32.66 | 2019-2020 | |
| Avion Pharmaceuticals | $30.93 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $17.52 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donielle Daigle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.